Skip to main content
Lancaster Resources Inc. logo

Lancaster Resources Inc. — Investor Relations & Filings

Ticker · LCR ISIN · CA51440M1023 CSE Mining and quarrying
Open in API
Filings indexed 334 across all filing types
Latest filing 2022-01-13 Regulatory Filings
Country CA Canada
Listing CSE LCR

About Lancaster Resources Inc.

https://lancaster-resources.com/

Lancaster Resources Inc. is a mineral exploration company dedicated to discovering and developing high-potential precious metal and critical mineral assets. The company focuses on gold, lithium, uranium, and polymetallic deposits across established mining jurisdictions, including North America and Australia. Key projects include the Lake Cargelligo Gold Project in New South Wales, Australia, and the Trans-Taiga Lithium Pegmatite Project and Lac Iris Polymetallic Property in Quebec. Lancaster emphasizes advancing projects responsibly with a commitment to sustainable environmental practices and long-term value creation.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing the appointment of Dr. Daniel Bainbridge to the Specialty Clinics Advisory Board of NeonMind Biosciences Inc. It focuses on the expertise and role of Dr. Bainbridge in enhancing safety protocols for intravenous ketamine treatment at NeonMind clinics. There is no financial data, regulatory filing references, or report attachments. The content is a corporate announcement about management advisory board changes rather than a formal management change announcement (which would be MANG) because it is about an advisory board appointment, not a board of directors or senior management change. It is not a financial report, earnings release, or regulatory filing. Therefore, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2022-01-13 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by NeonMind Biosciences Inc. It details a material change regarding the amendment of terms of outstanding share purchase warrants. The document is a regulatory filing reporting a material change event, not a full financial report, earnings release, or other specific report type. It is relatively short (1870 characters) and structured as a formal disclosure of a material event. This fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-12-21 English
Other.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'Amendment to Warrant Indenture' and details specific changes to the terms of a warrant indenture, including adjustments to the exercise price and expiry date. It is a formal amendment agreement between parties, not a financial report, earnings release, or regulatory filing. It relates to capital structure changes, specifically amendments to warrant terms, which falls under capital/financing updates. The document length is short and contains the full amendment text, not just an announcement or reference to a report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-12-18 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 5D ESCROW AGREEMENT' and contains detailed terms and conditions related to escrow securities, their deposit, release, transfer restrictions, and the role of the escrow agent. It references Exchange Policies and procedures for escrow related to a Qualifying Transaction and Tier 1 and Tier 2 issuer status. The content is a legal agreement outlining the handling of escrow securities rather than a financial report, regulatory filing, or announcement. It does not contain financial statements, earnings data, management discussion, or voting results. It is a contractual agreement document related to securities escrow arrangements, which does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The closest fitting category is Regulatory Filings (RNS) as a fallback for miscellaneous regulatory or compliance documents that do not fit other specific categories.
2021-12-17 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a Form 51-102F3 Material Change Report, which is a regulatory filing used to disclose material changes in a company, such as financing activities. The content describes the closing of the first tranche of a brokered private placement offering, detailing the issuance of units, debentures, warrants, and related commissions. The document is relatively short (2994 characters) and focuses on a financing event rather than a full financial report or earnings release. It is not an annual or interim report, nor a call transcript or AGM material. The document fits the category of Capital/Financing Update (CAP) as it provides detailed information about a capital raising transaction and related securities issuance.
2021-12-10 English
News release - English.pdf
Regulatory Filings
2021-12-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.